Re: It's a 10b5-1 sale (eom)
Yes.
But OT, it does show clearly a weakness in the 10b5-1 program. The plan did not designate the exact date, just a range. So, an insider COULD have made the trade a day earlier if they thought the data was bad.
The variation allowed within the planned sale program just does not work in the volatile biotech space.
I am certainly making no claim in this particular case, as I would have sold options on the open myself if I had this many.
As to the orriginal "nice compensation" post, it iis hard to know. He has been there for 13 years, so this could easily just be routine shares/options accumulated over that time.
